Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress

INTRODUCTION: Preliminary studies have shown that treatment with plasma exchange (PE) plus therapeutic albumin replacement in patients with Alzheimer's disease (AD) induced mobilization of plasma and cerebrospinal fluid amyloid β protein, associated with an improvement in memory and language fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boada, Mercè, López, Oscar, Núñez, Laura, Szczepiorkowski, Zbigniew M., Torres, Mireia, Grifols, Carlota, Páez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395854/
https://www.ncbi.nlm.nih.gov/pubmed/30859122
http://dx.doi.org/10.1016/j.trci.2019.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395854/
https://www.ncbi.nlm.nih.gov/pubmed/30859122
http://dx.doi.org/10.1016/j.trci.2019.01.001

Ejemplares similares